Technical information
Manufacturer
IDORSIA PHARMACEUTICALS FRANCE SAS
Presentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
w16tQxFu5myzsr10
